Health Behavior Management Program for Patients With Coronary Heart Disease

December 29, 2025 updated by: Zhou,Tong, The First Affiliated Hospital of Bengbu Medical University

Health Behavior Management Program for Patients With Coronary Heart Disease: A Clinical Study

Coronary artery disease (CAD) is a major chronic condition severely impacting population health in China. Our previous cohort studies revealed a high comorbidity rate between CAD and frailty, suggesting their interrelated equivalence as clinical syndromes with shared risk factors. In recent years, pilot integrated health management initiatives in China have demonstrated promising outcomes, yet evidence remains scarce regarding patients with concurrent CAD and frailty-a critical gap needing urgent resolution to achieve the "Healthy China 2030" strategic goals.

Building on prior research, this project aims to systematically evaluate existing management models for patients with CAD and frailty, develop a tailored health management framework, and implement it in clinical settings through empirical studies. The model will be optimized according to regional and demographic variations, leveraging cardiac rehabilitation centers, exercise-based interventions, and internet-enabled technologies to enhance coordinated care. By improving exercise efficacy, mitigating frailty progression, and enhancing quality of life, this initiative seeks to establish a robust chronic disease management system. The findings will provide evidence for formulating regional health policy and insurance strategies in Anhui Province, ultimately improving standardized management rates for chronic diseases.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bengbu, China
        • The First Affiliated Hospital of Bengbu Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of Coronary heart disease;
  • Proficiency in smartphone use;
  • Absence of visual, auditory, cognitive, or motor impairments.

Exclusion Criteria:

  • Inability or unwillingness to provide informed consent;
  • Physical or cognitive limitations preventing app operation;
  • Inability to attend in-person follow-up visits;
  • Concurrent severe comorbidities or malignancies, such as severe valvular heart disease, New York Heart Association class IV heart failure, severe aortic regurgitation, cancer, end-stage renal or liver disease;
  • Any other condition that could potentially impede exercise participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
The intervention consists of two parts: Health management model: Establish a "hospital-home" full-process health management service chain based on mobile health. Firstly, cardiac specialist nurses conduct a comprehensive assessment of each patient's cardiac rehabilitation status and implement individualized interventions. The specific intervention procedures are: "Assess the patient's current condition and capabilities - Promote the patient's awareness of the current situation - Develop and revise the cardiac rehabilitation plan - Supervise the implementation of the cardiac rehabilitation plan."
The development, application and evaluation of an innovative health management model for patients with coronary heart disease and frailty based on the "cardiac rehabilitation center" framework, exercise rehabilitation, and new technologies such as "mobile health".
Active Comparator: Control group
During the patient's hospital stay and after discharge, cardiovascular internal medical staff provide them with routine medical,nursing services and health education. In terms of basic drug treatment, the principles of secondary prevention for coronary heart disease should be followed. Routine nursing care and health education were delivered through verbal instruction and the "317 Nursing Education Platform." They were also advised to maintain a healthy lifestyle and participate in appropriate physical activities.
The development, application and evaluation of an innovative health management model for patients with coronary heart disease and frailty based on the "cardiac rehabilitation center" framework, exercise rehabilitation, and new technologies such as "mobile health".

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6MWD
Time Frame: 1month,3 months, 6 months
Measuring the maximum distance within 6 minutes.
1month,3 months, 6 months
The MOS item short from health survey
Time Frame: 1month,3 months, 6 months
Quality of life was assessed using the 36-Item Short Form Health Survey questionnaire
1month,3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty
Time Frame: 1month,3 months, 6 months
The FRAIL Scale
1month,3 months, 6 months
Grip strength
Time Frame: 1month,3 months, 6 months
Electronic grip device
1month,3 months, 6 months
Gait speed
Time Frame: 1month,3 months, 6 months
Stopwatch
1month,3 months, 6 months
Physical activity level
Time Frame: 1month,3 months, 6 months
The short version self-reported International Physical Activity Questionnaire.
1month,3 months, 6 months
Systolic pressure/Diastolic pressure
Time Frame: 1month,3 months, 6 months
Calibrated electronic blood pressure monitor
1month,3 months, 6 months
Major cardiovascular adverse events
Time Frame: 1month,3 months, 6 months
Major Adverse Cardiovascular Events (MACE) were defined as at least one of the following: heart failure, malignant arrhythmia, recurrent angina, recurrent myocardial infarction, cardiogenic shock, cardiac arrest, or sudden cardiac death.
1month,3 months, 6 months
Changes in Blood Lipid Biomarkers
Time Frame: 1 month, 3 months, 6 months
Changes in blood lipid biomarkers, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), were assessed.
1 month, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tong Zhou, The First Affiliated Hospital of Bengbu Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

December 29, 2025

First Posted (Actual)

January 9, 2026

Study Record Updates

Last Update Posted (Actual)

January 9, 2026

Last Update Submitted That Met QC Criteria

December 29, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Disease

Clinical Trials on Exercise rehabilitation plan and health management model for patients with coronary heart disease and frailty based on mobile health technology

Subscribe